11 Capital Partners LP Reduces Position in UnitedHealth Group Incorporated $UNH

Key Points

• 11 Capital Partners LP has reduced its stake in UnitedHealth Group by 8.5%, selling 1,450 shares, leaving it with 15,700 shares worth approximately $8.2 million.
• Analysts have set varying price targets for UnitedHealth Group, ranging from $317 to $440, with a consensus rating of "Moderate Buy" and a target price of $353.
• UnitedHealth Group recently declared a quarterly dividend of $2.21 per share, resulting in an annualized dividend yield of 2.9% and reflecting a payout ratio of 38.3%.

11 Capital Partners LP cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,700 shares of the healthcare conglomerate's stock after selling 1,450 shares during the period. UnitedHealth Group accounts for 2.7% of 11 Capital Partners LP's investment portfolio, making the stock its 15th biggest position. 11 Capital Partners LP's holdings in UnitedHealth Group were worth $8,223,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Bayforest Capital Ltd boosted its holdings in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its holdings in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares during the period. Copia Wealth Management bought a new position in UnitedHealth Group in the 4th quarter valued at $42,000. IAG Wealth Partners LLC bought a new position in UnitedHealth Group in the 1st quarter valued at $42,000. Finally, Investment Management Corp VA ADV bought a new position in UnitedHealth Group in the 4th quarter valued at $44,000. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Up 1.5%

Shares of NYSE UNH traded up $4.72 on Friday, reaching $315.10. 14,093,579 shares of the company's stock traded hands, compared to its average volume of 17,031,034. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The business's 50 day simple moving average is $288.78 and its two-hundred day simple moving average is $374.41. The company has a market cap of $285.38 billion, a price-to-earnings ratio of 13.65, a price-to-earnings-growth ratio of 2.00 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.8%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on UNH shares. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft cut their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Baird R W lowered shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Finally, Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $354.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.